MedTrace Logo

Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial

NCT02107183 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2017-07-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether, as compared with the Venturi mask, a nasal, high-flow oxygenation device (Optiflow) may reduce the extubation failure rate in patients needing oxygen therapy after extubation.

Conditions

  • Weaning Failure
  • Acute Respiratory Failure

Interventions

DEVICE

Optiflow (Fisher & Paykel Healthcare)

This device delivers high-flow oxygen through nasal cannula

DEVICE

Venturi mask

This device delivers low-flow oxygen at predetermined concentrations

Sponsors & Collaborators

  • Fisher and Paykel Healthcare

    collaborator INDUSTRY

  • Catholic University of the Sacred Heart

    lead OTHER

Principal Investigators

  • Salvatore Maurizio Maggiore, MD, PhD · Catholic University of the Sacred Heart, A. Gemelli Hospital, Rome, Italy

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • France
  • Greece
  • Italy
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02107183 on ClinicalTrials.gov